Drug Shortage Report for HYOSCINE BUTYLBROMIDE INJECTION BP
| Report ID | 255280 |
| Drug Identification Number | 02508419 |
| Brand name | HYOSCINE BUTYLBROMIDE INJECTION BP |
| Common or Proper name | HYOSCINE BUTYLBROMIDE |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYOSCINE BUTYLBROMIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 x 1 mL vial / fiole |
| ATC code | A03BB |
| ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-06-30 |
| Actual start date | 2025-06-30 |
| Estimated end date | 2025-10-31 |
| Actual end date | 2025-10-23 |
| Shortage status | Resolved |
| Updated date | 2025-10-24 |
| Company comments | Sandoz is covering Juno's hospital contracts. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.